Kestra Medical Technologies, Ltd. Common Stock (KMTS) is a publicly traded Healthcare sector company. As of October 30, 2026, KMTS trades at $30.60 with a market cap of $1.78B and a P/E ratio of -5.36. KMTS moved +2.38% today. Year to date, KMTS is +25.35%; over the trailing twelve months it is +9.63%. Its 52-week range spans $13.25 to $31.04. Analyst consensus is strong buy with an average price target of $30.00. Rallies surfaces KMTS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for KMTS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $30.60 |
| Market Cap | $1.78B |
| P/E Ratio | -5.36 |
| EPS | $-5.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $31.04 |
| 52-Week Low | $13.25 |
| Volume | 408.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $59.81M |
| Net Income | $-113.81M |
| Gross Margin | 40.48% |
6 analysts cover KMTS: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $30.00.